NuProbe BDA Technolo
NuProbe BDA Technology Enables Highly Sensitive Detection of Low-Level Variants for Oncology Research
May 03, 2023 10:00 ET | NuProbe USA Inc
Houston, May 03, 2023 (GLOBE NEWSWIRE) -- NuProbe, a genomics company developing ultrasensitive research assays for detecting and monitoring low-frequency mutations, gene fusions, and copy number...
MicrosoftTeams-image (5).png
USD 12.6 Bn Cancer Biomarkers Market to Grow at a CAGR of 9.9% During 2022 to 2031 - Global Analysis by Transparency Market Research
April 26, 2023 06:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 26, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, tThe global cancer biomarkers market size stood at USD 12.6 Bn in 2021. The market...
retinai_logo_RGB_black (1).png
RetinAI Joins Forces with Boehringer Ingelheim to Advance Novel Treatments for Patients with Geographic Atrophy using Artificial Intelligence
April 21, 2023 03:00 ET | RetinAI Medical AG
BERN, Switzerland and BOSTON, April 21, 2023 (GLOBE NEWSWIRE) -- RetinAI Medical AG (“RetinAI”), a leader in clinical and imaging data management software and advanced analytics using artificial...
MicrosoftTeams-image (5).png
Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study
April 13, 2023 17:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...
Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
April 11, 2023 05:00 ET | Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
MicrosoftTeams-image (5).png
Radiopharmaceutical Theranostics Market Size to Cross USD 12.4 Bn by 2031 | Transparency Market Research
April 03, 2023 17:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 04, 2023 (GLOBE NEWSWIRE) -- The global radiopharmaceutical theranostics market was valued at USD 3.0 Bn in 2022 and is projected to reach USD 12.4 Bn by...
Biomarkers Market is Expected to Reach $104.0 billion | MarketsandMarkets.
March 31, 2023 09:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, March 31, 2023 (GLOBE NEWSWIRE) -- The future of biomarkers is expected to be a very promising one. As new technologies and techniques continue to emerge, the use of biomarkers will become...
Biomarkers Market Size to Surpass USD 97.51 Billion by 2026 | With 12.1% CAGR
February 06, 2023 07:44 ET | Fortune Business Insights
Pune, India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The global Biomarkers Market size stood at USD 39.10 billion in 2018. The market is slated to expand USD 97.51 billion by 2026, exhibiting a CAGR of...
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 08, 2022 16:10 ET | Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
With 13% of CAGR, Neurological Biomarker Market to Gain $14+ Billion Revenue by 2027 | Exclusive Report by The Insight Partners
November 14, 2022 06:58 ET | The Insight Partners
New York, Nov. 14, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "Neurological Biomarker Market Size, Share, Growth, Trends and Forecast to 2027 – COVID-19 Impact and...